FR2499411A1 - Vaccin viral vivant cultive contre l'ecthyma contagieux des races ovines et son procede de preparation - Google Patents
Vaccin viral vivant cultive contre l'ecthyma contagieux des races ovines et son procede de preparation Download PDFInfo
- Publication number
- FR2499411A1 FR2499411A1 FR8102464A FR8102464A FR2499411A1 FR 2499411 A1 FR2499411 A1 FR 2499411A1 FR 8102464 A FR8102464 A FR 8102464A FR 8102464 A FR8102464 A FR 8102464A FR 2499411 A1 FR2499411 A1 FR 2499411A1
- Authority
- FR
- France
- Prior art keywords
- sheep
- virus
- vaccine
- cells
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 86
- 229960005486 vaccine Drugs 0.000 title claims abstract description 72
- 241001494479 Pecora Species 0.000 title claims abstract description 66
- 208000008034 Contagious Ecthyma Diseases 0.000 title claims abstract description 42
- 206010031071 Orf Diseases 0.000 title claims abstract description 42
- 201000005332 contagious pustular dermatitis Diseases 0.000 title claims abstract description 42
- 210000004927 skin cell Anatomy 0.000 title claims abstract description 20
- 230000002238 attenuated effect Effects 0.000 title claims abstract description 17
- 210000004027 cell Anatomy 0.000 claims abstract description 30
- 210000003491 skin Anatomy 0.000 claims abstract description 28
- 238000003306 harvesting Methods 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 12
- 238000012423 maintenance Methods 0.000 claims abstract description 10
- 229960004854 viral vaccine Drugs 0.000 claims abstract description 8
- 235000019687 Lamb Nutrition 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 30
- 210000003754 fetus Anatomy 0.000 claims description 26
- 208000015181 infectious disease Diseases 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- 241000283690 Bos taurus Species 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 12
- 230000001605 fetal effect Effects 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000002163 immunogen Effects 0.000 abstract description 5
- 230000003612 virological effect Effects 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 3
- 239000012888 bovine serum Substances 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 26
- 241000283903 Ovis aries Species 0.000 description 22
- 239000002609 medium Substances 0.000 description 17
- 230000000120 cytopathologic effect Effects 0.000 description 16
- 239000007788 liquid Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000002255 vaccination Methods 0.000 description 9
- 201000010582 ecthyma Diseases 0.000 description 7
- 230000036512 infertility Effects 0.000 description 6
- 238000010899 nucleation Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000005847 immunogenicity Effects 0.000 description 5
- 239000002356 single layer Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 206010039509 Scab Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 244000144992 flock Species 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 241001430197 Mollicutes Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000013553 cell monolayer Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004264 monolayer culture Methods 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8102464A FR2499411A1 (fr) | 1981-02-09 | 1981-02-09 | Vaccin viral vivant cultive contre l'ecthyma contagieux des races ovines et son procede de preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8102464A FR2499411A1 (fr) | 1981-02-09 | 1981-02-09 | Vaccin viral vivant cultive contre l'ecthyma contagieux des races ovines et son procede de preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2499411A1 true FR2499411A1 (fr) | 1982-08-13 |
| FR2499411B1 FR2499411B1 (enExample) | 1983-08-05 |
Family
ID=9254970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8102464A Granted FR2499411A1 (fr) | 1981-02-09 | 1981-02-09 | Vaccin viral vivant cultive contre l'ecthyma contagieux des races ovines et son procede de preparation |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2499411A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111139226A (zh) * | 2019-11-08 | 2020-05-12 | 内蒙古农业大学 | 一株羊口疮病毒弱毒株及其应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU456693B2 (en) * | 1970-10-09 | 1974-12-09 | Tasman Vaccine Laboratory Limited | Improvements; in virus vaccines |
-
1981
- 1981-02-09 FR FR8102464A patent/FR2499411A1/fr active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU456693B2 (en) * | 1970-10-09 | 1974-12-09 | Tasman Vaccine Laboratory Limited | Improvements; in virus vaccines |
Non-Patent Citations (2)
| Title |
|---|
| EXBK/73 * |
| EXBK/74 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111139226A (zh) * | 2019-11-08 | 2020-05-12 | 内蒙古农业大学 | 一株羊口疮病毒弱毒株及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2499411B1 (enExample) | 1983-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0623167B1 (fr) | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie | |
| Gibbs | Triosephosphate dehydrogenase and glucose-6-phosphate dehydrogenase in the pea plant | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| CA1277270C (fr) | Procede de culture du virus de la rhinotracheite infectieuse, notamment de la dinde, et vaccin prepare a partir du virus ainsi obtenu | |
| Ferry | Etiology of canine distemper | |
| CN104383530B (zh) | 水貂犬瘟热-细小病毒性肠炎二联活疫苗及其制备方法和用途 | |
| US11660337B2 (en) | Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus | |
| CN108066758B (zh) | 貉犬瘟热-细小病毒性肠炎二联活疫苗及其制备方法和用途 | |
| Tan et al. | Ecology of mycoplasmas in clinically healthy cats | |
| US2912361A (en) | Canine distemper vaccine and its preparation | |
| FR2499411A1 (fr) | Vaccin viral vivant cultive contre l'ecthyma contagieux des races ovines et son procede de preparation | |
| KR102716814B1 (ko) | 과수 화상병에 특이적인 신규 박테리오파지 및 이의 이용 | |
| CN104388394B (zh) | 水貂细小病毒弱毒疫苗株及其在制备水貂细小病毒弱毒疫苗中的用途 | |
| Demanche et al. | Assessment of Pneumocystis species carriage in captive primates | |
| US3255080A (en) | Live rabies virus vaccine and method for the production thereof | |
| FR2607392A1 (fr) | Procede pour la preparation d'une souche mutante de bordetella bronchiseptica utile pour la preparation d'un vaccin vivant attenue pour la prophylaxie des infections a b. bronchiseptica et vaccin vivant attenue contre la rhinite atrophique ainsi prepare | |
| RU2741643C1 (ru) | Ассоциированная вакцина против миксоматоза, пастереллёза и вирусной геморрагической болезни кроликов 1 и 2 типов | |
| O'Reilly | Study of an attenuated strain of feline infectious enteritis (panleucopaenia) virus I. Spread of vaccine virus from cats affected with feline respiratory disease | |
| RU2154495C2 (ru) | Инактивированная эмульсин-вакцина против сальмонеллеза телят | |
| RU2480238C1 (ru) | Вакцина ассоциированная против ньюкаслской болезни, реовирусного теносиновита и метапневмовирусной инфекции птиц инактивированная эмульсионная | |
| JPS585169B2 (ja) | ウイルス性混合生ワクチンの製法 | |
| RU2108385C1 (ru) | Аттенуированный штамм вируса чумы плотоядных virus pestis carnivorum | |
| CA1054053A (en) | Live virus culture vaccine against carnivore distemper and method of producing same | |
| WO2025218841A1 (en) | Bacterial preparation for treating the hatchery environment and use thereof | |
| FR2506615A1 (fr) | Vaccin contre les brucelloses humaines et son procede de fabrication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |